Retrospective Study of Clinical Effectiveness of Remdesivir in the Treatment of Moderate to Severe and critical Covid-19 Infections

Completed

• Conditions: Clinical effectiveness of remdesivir in moderate to severe and critical COVID-19; Remdesivir

• Registration Number: TCTR20211109004
• Lead Sponsor: /A

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2021-10-31
• Study Start: 2021-11-09
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 156

Inclusion Criteria

hospitalized patients with moderate to severe and critical COVID-19 illness and received remdesivir

Exclusion Criteria

mild COVID-19 illnes

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
clinical status at day 7 after treatment 7 days after treatment NEWS at day 7 after treatment

Secondary Outcome Measures

Name	Time	Method
clinical status at day 14 after treatment 14 days after treatment NEWS at day 14 after treatment,30 days mortality 30 days after treatment mortality rate,length of stay within one year after treatment days